Tumor Microenvironment in the Brain
暂无分享,去创建一个
[1] M. Moses,et al. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications. , 2006, EXS.
[2] Tarik Tihan,et al. The hypoxic response of tumors is dependent on their microenvironment. , 2003, Cancer cell.
[3] P. Sawchenko,et al. Bone Marrow-Derived Cells that Populate the Adult Mouse Brain Preserve Their Hematopoietic Identity , 2003, The Journal of Neuroscience.
[4] M J Gleason,et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] M. Berger,et al. Intracranial Microenvironment Reveals Independent Opposing Functions of Host αVβ3 Expression on Glioma Growth and Angiogenesis* , 2006, Journal of Biological Chemistry.
[6] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[7] S. Nag,et al. Morphology and molecular properties of cellular components of normal cerebral vessels. , 2003, Methods in molecular medicine.
[8] J. Posner,et al. Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.
[9] T. Shono,et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] B. Badie,et al. Impaired capacity for upregulation of MHC class II in tumor‐associated microglia , 2005, Glia.
[11] P. Ricciardi-Castagnoli,et al. Microglial cells induce cytotoxic effects toward colon carcinoma cells: Measurement of tumor cytotoxicity with a γ‐glutamyl transpeptidase assay , 1997, International journal of cancer.
[12] J. Tímár,et al. Circulating bone marrow‐derived endothelial progenitor cells: Characterization, mobilization, and therapeutic considerations in malignant disease , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[13] Jochen Herms,et al. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis , 2009, Glia.
[14] Harold E. Dvorak,et al. Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.
[15] B. Zlokovic,et al. Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.
[16] M. Colombo,et al. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. , 2003, Blood.
[17] J. Fukushi,et al. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin. , 2004, Molecular biology of the cell.
[18] D. Gutmann,et al. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. , 2007, Human molecular genetics.
[19] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[20] G. Nicolson,et al. Brain metastasis: role of trophic, autocrine, and paracrine factors in tumor invasion and colonization of the central nervous system. , 1996, Current topics in microbiology and immunology.
[21] D. Hicklin,et al. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. , 2007, Cancer research.
[22] A. Castelló,et al. 5D4 keratan sulfate epitope identifies a subset of ramified microglia in normal central nervous system parenchyma , 1998, Journal of Neuroimmunology.
[23] T. Iwama,et al. Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. , 2009, International journal of oncology.
[24] D. Gisselsson,et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] P. Black,et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Vogel,et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. , 2010, The Journal of clinical investigation.
[27] B Swolin,et al. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. , 1994, Genes & development.
[28] V. Tse,et al. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone marrow-derived endothelial precursor cells into brain tumors , 2005, Neurological research.
[29] T. Postolache,,et al. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge , 2005, Neurological research.
[30] R. Kerbel,et al. Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. , 2003, Cancer research.
[31] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[32] A. Koretsky,et al. Noninvasive imaging of the functional effects of anti-VEGF therapy on tumor cell extravasation and regional blood volume in an experimental brain metastasis model , 2009, Clinical & Experimental Metastasis.
[33] J. Kuratsu,et al. Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas , 2008, The Journal of pathology.
[34] W. Paulus,et al. Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.
[35] S. Brem,et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. , 1998, Journal of neurosurgery.
[36] Pieter Wesseling,et al. Antiangiogenic Therapy of Cerebral Melanoma Metastases Results in Sustained Tumor Progression via Vessel Co-Option , 2004, Clinical Cancer Research.
[37] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[38] T. Seike,et al. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis , 2010, Clinical & Experimental Metastasis.
[39] W. Hickey,et al. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.
[40] P. Rieckmann,et al. Microglial/macrophage expression of interleukin 10 in human glioblastomas , 1999, International journal of cancer.
[41] S. Leung,et al. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas , 1997, Acta Neuropathologica.
[42] W. Stallcup,et al. NG2 Proteoglycan Promotes Endothelial Cell Motility and Angiogenesis via Engagement of Galectin-3 and α3β1 Integrin , 2004 .
[43] Robert S. Kerbel,et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification , 2006, Nature Reviews Cancer.
[44] Steven Song,et al. The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.
[45] J. Price,et al. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[46] W. Stallcup,et al. Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan , 2004, Angiogenesis.
[47] H. Kettenmann,et al. Physiology of microglia. , 2011, Physiological reviews.
[48] I. Weissman,et al. Incorporation of Bone Marrow-derived Flk-1-expressing CD34+ Cells in the Endothelium of Tumor Vessels in the Mouse Brain , 2004, Neurosurgery.
[49] H. Tsuda,et al. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.
[50] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[51] I. Weissman,et al. Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture. , 2008, Stem cells and development.
[52] B. Melchior,et al. CNS immune privilege: hiding in plain sight , 2006, Immunological reviews.
[53] V. ter meulen,et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[54] M. Nikiforova,et al. Molecular diagnostics of gliomas. , 2011, Archives of pathology & laboratory medicine.
[55] M. Frotscher,et al. Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment , 2001, Nature Medicine.
[56] W. Hop,et al. Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas , 2007, Annals of neurology.
[57] Jochen Herms,et al. Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.
[58] B. Badie,et al. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.
[59] R. Jain,et al. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. , 2006, Blood.
[60] G. Bergers,et al. The bone marrow constitutes a reservoir of pericyte progenitors , 2006, Journal of leukocyte biology.
[61] S. Vandenberg,et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.
[62] K. Williams,et al. Genetically modified CD34+ hematopoietic stem cells contribute to turnover of brain perivascular macrophages in long-term repopulated primates. , 2009, The American journal of pathology.
[63] B. Barres,et al. Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.
[64] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[65] L. Salford,et al. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. , 2012, Neurosurgery.
[66] Masahiro Inoue,et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. , 2009, Cancer cell.
[67] N. Sibson,et al. The Vascular Basement Membrane as “Soil” in Brain Metastasis , 2009, PloS one.
[68] G. Mckhann,et al. Defective Receptor Expression and Dendritic Cell Differentiation of Monocytes in Glioblastomas , 2006, Neurosurgery.
[69] M. Berens,et al. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. , 2007, Journal of the National Cancer Institute.
[70] W. Fierz,et al. Astrocytes present myelin basic protein to encephalitogenic T-cell lines , 1984, Nature.
[71] B. Felding-Habermann,et al. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. , 2010, The American journal of pathology.
[72] W. Streit,et al. Role of microglia in the central nervous system's immune response , 2005, Neurological research.
[73] Qiulian Wu,et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.
[74] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.
[75] S. Dimmeler,et al. Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.
[76] K. Hirschi,et al. Hemato-vascular origins of endothelial progenitor cells? , 2010, Microvascular research.
[77] K. Gollahon,et al. Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.
[78] D. Hicklin,et al. Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors , 2006, Science.
[79] J. Li,et al. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. , 2000, Cancer research.
[80] L. Ricci-Vitiani,et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.
[81] R. Ádány,et al. Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.
[82] I. Fidler,et al. Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain. , 2009, Cancer research.
[83] B. Badie,et al. Expression of Fas ligand by microglia: possible role in glioma immune evasion , 2001, Journal of Neuroimmunology.
[84] B. Felding-Habermann,et al. Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain , 2009, Proceedings of the National Academy of Sciences.
[85] M. Sporn,et al. The tumour microenvironment as a target for chemoprevention , 2007, Nature Reviews Cancer.
[86] J. Julien,et al. Increased glioma growth in mice depleted of macrophages. , 2007, Cancer research.
[87] X. Moore,et al. Endothelial progenitor cells’ ‘homing’ specificity to brain tumors , 2004, Gene Therapy.
[88] D. Ojha. A computational analysis of ordering in ABCHN at the nematic–isotropic transition , 2006, Journal of molecular modeling.
[89] Gerhard Christofori,et al. The angiogenic switch in carcinogenesis. , 2009, Seminars in cancer biology.
[90] J. Antel,et al. Expression and Modulation of HLA-DR on Cultured Human Adult Astrocytes , 1991, Journal of neuropathology and experimental neurology.
[91] David E. Anderson,et al. Astrocytic Regulation of Human Monocytic/Microglial Activation1 , 2008, The Journal of Immunology.
[92] M. Graeber,et al. Microglia only weakly present glioma antigen to cytotoxic T cells , 1999, International Journal of Developmental Neuroscience.
[93] K. Franks,et al. Overview of the diagnosis and management of brain, spine, and meningeal metastases , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[94] P. Shannon,et al. Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1. , 2005, Neoplasia.
[95] Z. Werb,et al. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.
[96] F. Sotgia,et al. Towards a new “stromal-based” classification system for human breast cancer prognosis and therapy , 2009, Cell cycle.
[97] Y. Olsson,et al. Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells , 1995, Journal of the Neurological Sciences.
[98] Manfred Schmidt,et al. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.
[99] Masami Niwa,et al. Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.
[100] Isaac Yang,et al. The role of microglia in central nervous system immunity and glioma immunology , 2010, Journal of Clinical Neuroscience.
[101] D. Pardoll,et al. Targeted gene therapy to antigen-presenting cells in the central nervous system using hematopoietic stem cells , 2005, Neurological research.
[102] W. Cavenee,et al. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. , 2001, Cancer research.
[103] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[104] D. Scadden,et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. , 2006, Cancer research.
[105] R. Sawaya,et al. Management of brain metastases: the indispensable role of surgery , 2009, Journal of Neuro-Oncology.
[106] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[107] P. Kelly,et al. Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. , 2009, Journal of neurosurgery.
[108] S. Renninger,et al. Minor Contribution of Bone Marrow‐Derived Endothelial Progenitors to the Vascularization of Murine Gliomas , 2003, Brain pathology.
[109] M. Sofroniew,et al. Astrocytes: biology and pathology , 2009, Acta Neuropathologica.
[110] B. Bay,et al. Differential Reactions of Microglia to Brain Metastasis of Lung Cancer , 2006, Molecular medicine.
[111] M. Andreeff,et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.
[112] J. Buckner,et al. The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. , 2007, Neuro-oncology.
[113] Paolo Serafini,et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.
[114] Y. Sawamura,et al. Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes. , 1990, Journal of neurosurgery.
[115] P. Steeg,et al. Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.
[116] K. Toyka,et al. In situ detection of transforming growth factor-β mRNA in experimental rat glioma and reactive glial cells , 1994, Neuroscience Letters.
[117] W. You,et al. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse. , 2010, Developmental biology.
[118] C. Bucana,et al. Differential permeability of the blood-brain barrier in experimental brain metastases produced by human neoplasms implanted into nude mice. , 1992, The American journal of pathology.
[119] Seung-Ki Kim,et al. Human Neural Stem Cells Target Experimental Intracranial Medulloblastoma and Deliver a Therapeutic Gene Leading to Tumor Regression , 2006, Clinical Cancer Research.
[120] I. Fidler,et al. Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis. , 2009, International journal of oncology.
[121] R. Tanaka,et al. Antigen-presenting capability of glial cells under glioma-harboring conditions and the effect of glioma-derived factors on antigen presentation , 2000, Journal of Neuroimmunology.
[122] Y. Olsson,et al. Hematogenous metastases of the human brain – Characteristics of peritumoral brain changes: A review , 1997, Journal of Neuro-Oncology.
[123] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[124] F. Heppner,et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion , 2009, Proceedings of the National Academy of Sciences.
[125] M. Sofroniew,et al. Reactive Astrocytes in Neural Repair and Protection , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[126] A. Straube,et al. Glioblastoma-dependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro , 2011, Journal of Neuro-Oncology.
[127] N. Van Rooijen,et al. Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.
[128] P. Vajkoczy,et al. Circulating endothelial progenitor cells in malignant gliomas. , 2010, Journal of neurosurgery.
[129] Nico van Rooijen,et al. Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.
[130] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[131] Peter Canoll,et al. Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis , 2006, Glia.
[132] M. Berger,et al. Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis. , 2006, The Journal of biological chemistry.
[133] W. You,et al. Tumorigenesis and Neoplastic Progression Collagen VI Ablation Retards Brain Tumor Progression Due to Deficits in Assembly of the Vascular Basal Lamina , 2012 .
[134] A. Sica,et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.
[135] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[136] Bengt R. Johansson,et al. Pericytes regulate the blood–brain barrier , 2010, Nature.
[137] S. Sengupta,et al. Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma , 2010, PloS one.
[138] B. Döme,et al. A Novel Concept of Glomeruloid Body Formation in Experimental Cerebral Metastases , 2003, Journal of neuropathology and experimental neurology.
[139] C. Bucana,et al. The seed and soil hypothesis: vascularisation and brain metastases. , 2002, The Lancet. Oncology.
[140] Behnam Badie,et al. Role of microglia in glioma biology , 2001, Microscopy research and technique.
[141] F. Gage,et al. Fibroblast growth factors stimulate nerve growth factor synthesis and secretion by astrocytes , 1991, Brain Research.
[142] J. J. Bernstein,et al. Glioblastoma Cells Do Not Intravasate into Blood Vessels: 124 , 1995, Neurosurgery.
[143] Tracy T Batchelor,et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. , 2007, Cancer cell.
[144] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[145] N. Davoust,et al. From bone marrow to microglia: barriers and avenues. , 2008, Trends in immunology.
[146] Yoon Kyung Choi,et al. Blood-brain barrier interfaces and brain tumors , 2006, Archives of pharmacal research.
[147] Philippe Soriano,et al. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. , 1994, Genes & development.
[148] I. Bechmann,et al. Astrocyte-induced T cell elimination is CD95 ligand dependent , 2002, Journal of Neuroimmunology.
[149] Luigi Naldini,et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.
[150] C. Brennan,et al. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. , 2010, Cell stem cell.
[151] K. Aldape,et al. Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. , 2010, Neoplasia.
[152] M. Berger,et al. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. , 1999, Neuro-oncology.
[153] W. Hickey,et al. Contents , 2004, Journal of Neuro-Oncology.
[154] B. Brew,et al. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification , 2004, Journal of leukocyte biology.
[155] V. Nguyen,et al. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF‐β, IL‐4, IL‐13 and IL‐10 , 1999, European journal of immunology.
[156] Alberto Mantovani,et al. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. , 2010, Current opinion in immunology.
[157] D. Hess,et al. Hematopoietic origin of microglial and perivascular cells in brain , 2004, Experimental Neurology.
[158] D. Waisman,et al. Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator–Plasmin Cascade , 2003, The Journal of Neuroscience.
[159] C. Betsholtz,et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.
[160] L. Naldini,et al. Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. , 2004, The Journal of clinical investigation.
[161] W. Thomas,et al. Cellular forms and functions of brain microglia , 1994, Brain Research Bulletin.
[162] M. Manns,et al. Myeloid derived suppressor cells in human diseases. , 2011, International immunopharmacology.
[163] Suyun Huang,et al. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice , 2004, Clinical & Experimental Metastasis.
[164] W. Roggendorf,et al. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study , 2001, Acta Neuropathologica.
[165] H. Wilms,et al. In vitro-staining specificity of the antibody 5-D-4 for microglia but not for monocytes and macrophages indicates that microglia are a unique subgroup of the myelomonocytic lineage , 1999, Journal of Neuroimmunology.
[166] J. Tonn,et al. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. , 1997, Anticancer research.
[167] A. Vortmeyer,et al. Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization , 2008, Clinical & Experimental Metastasis.
[168] V. Tse,et al. The cancer stem cell-vascular niche complex in brain tumor formation. , 2008, Stem cells and development.
[169] M. Neeman,et al. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[170] Kristi Kincaid,et al. M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.
[171] S. Vandenberg,et al. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. , 2008, Neuro-oncology.
[172] J. Talmadge. Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy , 2007, Clinical Cancer Research.
[173] M. Mrugala,et al. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. , 2009, Neurology.
[174] A. Zeiher,et al. Mobilizing endothelial progenitor cells. , 2005, Hypertension.
[175] Andrea Falini,et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. , 2008, Cancer cell.
[176] I. Nir,et al. Permeability of blood vessels in experimental gliomas: uptake of 99mTc-glucoheptonate and alteration in blood-brain barrier as determined by cytochemistry and electron microscopy. , 1989, Neurosurgery.